A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery. (Q46988001)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16533273 AND SRC:MED&resulttype=core&format=json

17 January 2020

title

A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16533273 AND SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16533273 AND SRC:MED&resulttype=core&format=json

17 January 2020

Keyvan Karkouti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16533273 AND SRC:MED&resulttype=core&format=json

17 January 2020

author name string

W Scott Beattie

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16533273 AND SRC:MED&resulttype=core&format=json

17 January 2020

Kathleen M Dattilo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16533273 AND SRC:MED&resulttype=core&format=json

17 January 2020

Stuart A McCluskey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16533273 AND SRC:MED&resulttype=core&format=json

17 January 2020

Mohammed Ghannam

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16533273 AND SRC:MED&resulttype=core&format=json

17 January 2020

Ahmed Hamdy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16533273 AND SRC:MED&resulttype=core&format=json

17 January 2020

Ludwik Fedorko

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16533273 AND SRC:MED&resulttype=core&format=json

17 January 2020

Terrence M Yau

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16533273 AND SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16533273 AND SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16533273 AND SRC:MED&resulttype=core&format=json

17 January 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16533273 AND SRC:MED&resulttype=core&format=json

17 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16533273 AND SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

327-338

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16533273 AND SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2006.00724.X

Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2006.00724.X

Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2006.00724.X

Pharmacological approaches to reducing allogeneic blood exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2006.00724.X

Pharmacokinetics of tranexamic acid during cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2006.00724.X

Recombinant factor VIIa for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2006.00724.X

The independent association of massive blood loss with mortality in cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2006.00724.X

Invited commentary: propensity scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2006.00724.X

Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2006.00724.X

Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2006.00724.X

Aprotinin and tranexamic acid for high transfusion risk cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2006.00724.X

Reducing allogeneic transfusion in cardiac surgery: a randomized double-blind placebo-controlled trial of antifibrinolytic therapies used in addition to intra-operative cell salvage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2006.00724.X

Hemodilution during cardiopulmonary bypass is an independent risk factor for acute renal failure in adult cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2006.00724.X

Renal Dysfunction After Cardiac Surgery with Normothermic Cardiopulmonary Bypass: Incidence, Risk Factors, and Effect on Clinical Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1537-2995.2006.00724.X